ArticleOncogene2025

Leveraging RAS-mSIN1 interaction to selectively inhibit mTORC2 employing competitive RAS binding peptide: implications in breast cancer metastasis.

Javed Miyan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.